This study aimed to evaluate pSTAT3 and CTLA4 expression levels and their possible roles as prognostic and predictive biomarkers in CRC using immunohistochemistry (IHC).<h4>Methods</h4>This retrospective study included 113 CRC patients. The gene discussed is CTLA4; the disease is colorectal carcinoma.